ZetrOZ Systems

Creator of wearable sustained acoustic medicine technology to educate clinicians on device's effectiveness in soft tissue healing and regenerative medicine treatment.

The sam®x1 is an effective tool for treating acute musculoskeletal injuries and the first wireless long-duration ultrasound system that is FDA-cleared for prescription home use.

The Ambassador Program seeks athletic trainers and social media influencers, amateurs and professionals alike, to promote the proven real-world benefits of sustained acoustic medicine.

The sam®x1 wireless sustained acoustic medicine device helps sports and regenerative medicine providers return their patients to everyday activities.

The specialized ultrasound treatment is now available to medical professionals across the United States.

Board-certified physicians use the ZetrOZ Systems sustained acoustic medicine device for injury healing and pain relief without invasive surgery or potentially addictive and dangerous medications.

First-year graduate students at Merrimack College taking Therapeutic Modalities will learn about the effects and benefits of long-duration, sustained acoustic medicine (sam®) on soft-tissue healing.

ZetrOZ's sam®️ technology promotes soft tissue healing, helping patients return to work sooner and preventing more severe injuries; the only FDA-cleared home-use multi-hour ultrasound stimulator.

ZetrOZ Systems will showcase its sustained acoustic medicine (sam®) technology, a non-invasive, non-systemic treatment option for soft-tissue injuries experienced in the workplace and beyond. The companies' partnerships with self-insured and insurance providers has expanded access to millions of lives in America.

The wireless, long-duration, continuous, ultrasound, patch-based stimulator delivers 33 times more treatment than pulsed ultrasound devices and is authorized by the FDA for prescription home use in the United States of America.

A sam® regimen prioritizes healing beyond the pain to emphasize the importance of returning patients fully back to health to minimize the risk of chronic, recurring injuries.

New clinical research sheds light on the use of sam®, a medical ultrasound device for prescription home use, for pain mitigation in soft tissue injuries.

At a recent conference of professional hockey trainers, ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine (sam®) for soft tissue injury healing, presented results of studies indicating the medical device is highly effective at treating the types of injuries hockey players frequently experience.

sam® by Zetroz Systems utilizes high-frequency, low-intensity continuous ultrasound to facilitate the healing of injured musculoskeletal tissue in the home of the patient.

Effective management of a company's intellectual property can create significant advantages, crucial in today's competitive health technology marketplace.

Creator of sustained acoustic medicine soft tissue healing device reports that even FDA-cleared devices backed by body of research and millions of successful treatments still face hurdles.

ZetrOZ Systems' musculoskeletal ultrasound device facilitates return to regular activities

Innovative medical technologies like the sam® device promote soft tissue healing

Sustained Acoustic Medicine developer avoids supply chain tangles to supply healthcare providers with needed medical intervention.

New research demonstrates how sustained acoustic medicine (SAM) accelerates healing and recovery from soft tissue injury common in college and professional sports

Innovative, wearable, FDA-cleared long-duration ultrasound device proven effective in rehabilitation and pain management, medical journal review reports.

Dr. George Lewis, inventor of sam® soft tissue healing pain relief ultrasound device, to review 2022 clinical research on technology and patient outcomes

Sustained acoustic medicine (sam®) device for soft tissue injuries is available for patients and healthcare providers to amplify the body's natural ability to heal by increasing local circulation

Wearable ultrasound technology from ZetrOZ Systems meets patients' need for for drug-free, non-invasive treatment extending healing to the home

Wearable ultrasound therapy for home use assists in healing and reduces reliance on narcotic pain medications, which only mask pain

The pain management ultrasound device helps heal injuries and return employees back to work without surgery or narcotics.

ZetrOZ's Sustained Acoustic Medicine (samⓇ) backed by 15 years of research, 30 clinical studies, 300,000 patients

The wearable sustained acoustic medicine (sam®) device has been leveraged by athletes to help treat injuries sustained during competition

The sustained acoustic medicine treatment reduces the cause of pain, accelerates the healing process, delivers mechanical compression, increases deep circulation, enhances oxygen and nutrient delivery and provides daily therapy multiple hours per day. The technology is proven in over 20 clinical trials supporting the efficacy of treatment.

The 2020 FDA-approved, non-invasive, home-use, SAM treatment facilitates the healing of a wide range of injuries and significantly reduces pain - without drugs or surgery. A gamechanger for chronic pain patients and the Veteran Health Administration strategic initiative to reduce opioid abuse.